Stay Updated on GLP-1 Research: New studies, treatment options, safety findings, and obesity-health breakthroughs are emerging every month. If you'd like practical, evidence-based updates on GLP-1 medications, consider subscribing to our newsletter at newsletter. If you're already a subscriber, thank you for supporting GLP1Guide.
Introduction
Clinical trials are considered the gold standard for evaluating medication safety. Before a drug reaches the market, researchers carefully track side effects among thousands of participants to understand both its benefits and risks.
However, clinical trials have limitations.
Participants are carefully selected, monitored under controlled conditions, and followed for a limited period of time. Real-world patients often have different experiences once a medication is used by millions of people across different ages, lifestyles, and health conditions.
This is one reason researchers have increasingly started looking at social media platforms as a source of health information.
A new study published on arXiv analyzed more than 410,000 Reddit posts discussing semaglutide and tirzepatide. The goal was simple: understand what people are actually saying about their experiences with GLP-1 medications outside the clinical-trial environment. The findings suggest that while most reported side effects align with what doctors already know, some less-recognized symptoms may deserve further investigation.
Why Researchers Studied Reddit
At first glance, Reddit may seem like an unusual source for medical research.
However, online communities often contain detailed discussions about treatment experiences that patients may not report during formal clinical studies.
Researchers analyzed Reddit posts mentioning:
- Semaglutide
- Ozempic
- Wegovy
- Tirzepatide
- Mounjaro
- Related GLP-1 therapies
- 410,198 posts
- 67,008 self-identified GLP-1 users
- Discussions spanning from May 2019 through June 2025
Nearly Half of Users Reported Side Effects
One of the headline findings was that 43.5% of self-reported users described experiencing at least one side effect while using semaglutide or tirzepatide.
This should not be interpreted as meaning that exactly 43.5% of all GLP-1 users experience side effects.
People experiencing problems are often more likely to post online than people who have no issues at all.
Nevertheless, the data provides an interesting snapshot of what users commonly discuss in real-world settings.
The Most Frequently Reported Side Effects
The study found that gastrointestinal symptoms dominated online discussions.
The most frequently reported side effects included:
Nausea
Nausea was the most commonly discussed symptom, reported by approximately 36.9% of users who mentioned side effects.
This aligns closely with clinical trial data and current prescribing information.
Fatigue
Fatigue appeared in approximately 16.7% of side-effect reports.
Many users described feeling unusually tired, particularly during dose escalation periods.
Some experts believe fatigue may be related to:
- Reduced calorie intake
- Rapid weight loss
- Nutritional deficiencies
- Adjustment to appetite changes
Vomiting
Approximately 16.3% of users discussed vomiting.
This side effect was particularly common among people who increased doses rapidly or consumed large meals while taking the medication.
Constipation
Constipation was reported by approximately 15.3% of users.
This finding is consistent with real-world physician experience and has become one of the most common reasons patients seek practical dietary advice while using GLP-1 medications.
Diarrhea
Approximately 12.6% of users reported diarrhea.
Interestingly, some patients reported alternating between constipation and diarrhea during different stages of treatment.
The More Surprising Findings
The most interesting aspect of the study was not the common side effects.
It was the symptoms that appeared less frequently but repeatedly enough to attract researchers' attention.
These included:
- Menstrual irregularities
- Changes in menstrual cycle timing
- Chills
- Hot flashes
- Temperature regulation issues
Importantly, the study does not prove that GLP-1 drugs directly cause these symptoms.
It simply shows that many users are discussing them.
Why Social Media Matters for Drug Safety
Historically, many medication side effects were only recognized after widespread use.
Clinical trials may involve thousands of participants.
Real-world use involves millions.
This creates opportunities to identify rare or unexpected experiences that might not appear during pre-approval studies.
Researchers increasingly view social media as a form of "digital pharmacovigilance" — the ongoing monitoring of medication safety using large-scale online data.
Rather than replacing clinical trials, these methods help identify new questions that deserve further investigation.
What This Study Does NOT Prove
One of the most important limitations of the research is that Reddit posts are self-reported.
Researchers cannot independently verify:
- Whether users were actually taking the medication
- The dose they were using
- Other medical conditions
- Concurrent medications
- Lifestyle factors
For example, a person experiencing fatigue while taking semaglutide may actually be experiencing:
- Reduced calorie intake
- Sleep issues
- Iron deficiency
- Rapid weight loss
This is why researchers describe the findings as potential safety signals rather than confirmed side effects.
What This Means for Patients
For most patients, the study should be reassuring rather than alarming.
The majority of commonly reported symptoms matched what doctors already know about GLP-1 medications:
- Nausea
- Vomiting
- Constipation
- Diarrhea
- Fatigue
Patients should remember that side effects vary significantly from person to person.
Many users experience only mild symptoms, while others require dose adjustments or additional support.
The Bigger Picture
The rapid rise of GLP-1 medications has created one of the largest real-world health experiments in modern medicine.
Millions of people are now using semaglutide and tirzepatide for obesity and diabetes management.
As a result, researchers are increasingly turning to unconventional data sources—including social media—to better understand patient experiences.
Studies like this do not replace clinical trials.
Instead, they complement them by revealing how medications perform in everyday life.
That may ultimately help physicians identify emerging concerns more quickly and provide better guidance to patients.
The Takeaway
A new analysis of more than 410,000 Reddit posts found that gastrointestinal symptoms remain the most commonly discussed side effects of semaglutide and tirzepatide. However, researchers also identified less-recognized experiences such as menstrual changes and temperature-related symptoms that may warrant further investigation.
The findings do not prove that GLP-1 drugs directly cause these symptoms, but they highlight the growing role of social media in helping researchers understand real-world medication experiences.
As GLP-1 use continues to expand worldwide, patient-reported experiences may become an increasingly important part of medication safety monitoring.
References
- Self-Reported Side Effects of Semaglutide and Tirzepatide in Online Communities
- Utilizing AI and Social Media Analytics to Discover Adverse Side Effects of GLP-1 Receptor Agonists
- FDA Prescribing Information for Wegovy
- FDA Prescribing Information for Zepbound
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified physician before starting, changing, or stopping any medication.